"ENTACOVER 0.5: Entecavir IP (0.5mg) - Targeted Hepatitis B Virus Management"

May 08, 2024

ENTACOVER 0.5

Entecavir IP (0.5mg)

ENTACOVER 0.5 offers targeted treatment for chronic hepatitis B with its key component, Entecavir IP (0.5mg). Designed to inhibit the replication of the hepatitis B virus (HBV), this medication is essential for patients seeking to manage their viral load effectively and improve liver function.

Composition and Mechanism

Entecavir, the active ingredient in ENTACOVER 0.5, is a nucleoside analog that:

  • Blocks HBV DNA replication: By interfering with the viral DNA polymerase, Entecavir halts the replication cycle of the hepatitis B virus, leading to a decrease in viral load and an improvement in liver health.

Benefits of ENTACOVER 0.5

  • Viral Load Reduction: Entecavir is highly effective in reducing the hepatitis B viral load, especially in patients who have not been previously treated with antiviral drugs.
  • Liver Health Improvement: Continued use of ENTACOVER 0.5 can lead to improvements in liver histology, which may decrease the risk of progressing to cirrhosis or liver cancer.
  • Lower Resistance Development: Entecavir has a favorable resistance profile compared to other antivirals used in hepatitis B treatment, making it an excellent option for long-term management.

Usage Instructions

ENTACOVER 0.5 should be taken once daily on an empty stomach, ideally at least 2 hours after the last meal or 2 hours before the next meal. It's important to adhere strictly to the dosing schedule prescribed by your healthcare provider to maximize the drug’s efficacy and safety.

Side Effects and Considerations

The most common side effects include headache, fatigue, and nausea, which are generally mild. However, more severe reactions, such as lactic acidosis and serious liver complications, may occur and require immediate medical attention.

Availability and Pricing

ENTACOVER 0.5 is available through prescription at pharmacies. Patients should consult their healthcare provider for specific pricing details and to obtain a prescription, ensuring they have access to this critical medication.

Conclusion

ENTACOVER 0.5 stands as a robust tool in the management of chronic hepatitis B, providing patients with a reliable method to control the viral load and enhance liver function. Its specific formulation and strength make it an indispensable part of hepatitis B therapy.

Disclaimer: Always use ENTACOVER 0.5 under the direction of a healthcare professional. Regular monitoring of liver function tests and HBV DNA levels is crucial to track the effectiveness of the therapy and address any potential side effects. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. gynecology, Pediatrics, Dental care, and Dermatology.The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW

 

SHARE WITH